Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-22-000042
Filing Date
2022-03-09
Accepted
2022-03-09 16:16:55
Documents
6

Document Format Files

Seq Description Document Type Size
1 MODERNA, INC. - DEFA14A lmrna2022_def14a.htm DEFA14A 7893
2 GRAPHIC box1.jpg GRAPHIC 1082
3 GRAPHIC checkbox1.jpg GRAPHIC 1317
4 GRAPHIC im2140623574x1773569987.jpg GRAPHIC 28148
5 GRAPHIC lmrna003_notice1.jpg GRAPHIC 335705
6 GRAPHIC lmrna003_notice2.jpg GRAPHIC 274235
  Complete submission text file 0001308179-22-000042.txt   891733
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38753 | Film No.: 22725562
SIC: 2836 Biological Products, (No Diagnostic Substances)